107 Followers on Owler

Pear

Pear Therapeutics is a prescription digital therapeutic platform that offers clinical engagement and patient tracking solutions for clinicians. Read more

Corey McCann's photo - President & CEO of Pear

President & CEO

Corey McCann

CEO Approval Rating

91/100

Founded:

2013

Status:

PrivateIndependent Company

PEAR TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Omada Health is Pear's #1 competitor. Omada Health was founded in San Francisco, California} in 2011. Omada Health operates in the Health Care Technology industry. Compared to Pear, Omada Health generates $90.3M more revenue.

Click Therapeutics is one of Pear's top competitors. Click Therapeutics was founded in 2012 in New York, New York. Click Therapeutics operates in the Health Care Technology industry. Click Therapeutics generates $4M less revenue than Pear.

Kaia Health is a top competitor of Pear. Kaia Health was founded in 2016, and is headquartered in Munich, Bavaria. Kaia Health is in the Health Care Technology industry. Kaia Health generates $550K more revenue vs. Pear.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $13.8M a good estimate for Pear's revenue?

Pear Acquisitions

No recent acquisitions found related to Pear

Pear Funding History

Since Pear was founded in 2013, it has participated in 7 rounds of funding. In total Pear has raised $284.3M. Pear's last funding round was on Mar 2021 for a total of $20.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series D
Mar 2021
$20M
-
Series D
Dec 2020
$80M
Debt
Jul 2020
$50M
Series C
Dec 2018
$64.3M
Series B
Dec 2017
$50M

Since Pear was founded in 2013, it has participated in 7 rounds of funding. In total Pear has raised $284.3M. Pear's last funding round was on Mar 2021 for a total of $20.0M

Pear Investments

No recent investments found related to Pear

Pear News

April 22, 2021Long Island Business News

Northwell, Pear Therapeutics partner with new treatment for substance-abuse disorders

Feedback from patients and clinicians is positive, medical experts say.... See more »
April 12, 2021MarketScreener

New Study, with Pear Therapeutics, to Identify Best Practices for Implementation in Primary Care of Digital Treatment for Substance Use Disorders

(marketscreener.com) Researchers to compare different approaches to integrating Pear's reSET® and reS... See more »
April 6, 2021Drug Delivery Business

Pear Therapeutics inks multiple agreements to expand digital therapeutic platform

Pear Therapeutics announced today that it entered into multiple agreements to bolster its prescriptio... See more »
April 6, 2021FierceBiotech

Pear Therapeutics to take digital treatments physical with sensor, activity tracker deals

Pear Therapeutics to take digital treatments physical with sensor, activity tracker deals chale Tue, ... See more »
April 2, 2021Drug Delivery Business

Prescryptive to offer benefit coverage for Pear Therapeutics opioid use disorder treatments

Pear Therapeutics announced today that Prescryptive Health will offer and administer benefit coverage... See more »
March 9, 2021Global Legal Chronicle

Pear Therapeutics' $20M Series D Extension

Foley Hoag LLP advised Pear Therapeutics, Inc. on the deal. Pear Therapeutics, Inc., a pioneer of pre... See more »

Pear Blogs

October 11, 2016Pear Therapeutics Blog

Utilizing Software Modules as an Enhancement to Pharmaceuticals for Chronic Conditions Is Poised to Be Critical Component of Digital Healthcare

NEW YORK, NY-(Marketwired - Oct 6, 2016) - Psilos Group, in its seventh annual Outlook outlining majo... See more »
September 8, 2016Pear Therapeutics Blog

Pear Therapeutics CEO, Corey McCann MD PhD, to speak at the 13th Annual Connected Health Symposium

Health, technology, research, human behavior and public policy intersect at Connected Health Symposiu... See more »
August 3, 2016Pear Therapeutics Blog

PEAR's Substance Use Disorder therapy, reSETTM, featured in Neurotech Insights

PEAR THERAPEUTICS ADVANCES THE FIRST REGULATED DIGITAL THERAPIES FOR ADDICTION Pear Therapeutics has ... See more »
May 23, 2016Pear Therapeutics Blog

To FDA or Not to FDA is Hot Topic at Neurogaming Conference

By Lesley McClurg Wandering through booths at a neurogaming conference in downtown San Francisco this... See more »
May 4, 2016Pear Therapeutics Blog

Pear Therapeutics CEO, Corey McCann, to Speak at Digital Health Summer Summit

The Fifth Annual Digital Health Summer Summit, co-located this year with BIO International Convention... See more »
February 3, 2016Pear Therapeutics Blog

Pear Therapeutics Closes $20 Million Financing

BOSTON, MA and SAN FRANCISCO, CA - Pear Therapeutics (PEAR), the creator of prescription digital ther... See more »
November 6, 2015Pear Therapeutics Blog

Video game designers tout games as prescription therapies

Inside the push for prescription video games to treat autism, anxiety, even Alzheimer's By: Rebecca R... See more »

Pear Press Releases

February 10, 2021Business Wire

Pear Therapeutics to Participate in BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Pear Therapeutics to Participate in BTIG Virtual MedTech, Di... See more »
December 11, 2020Business Wire

Pear Therapeutics Announces Publication of Economic Analysis Assessing the Cost-Effectiveness of reSET-O in Treating Opioid Use Disorder (OUD)

BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Pear Therapeutics Announces Publication of Economic Analysis... See more »
December 2, 2020Business Wire

Pear Therapeutics to Participate in the 2020 RBC Capital Markets Healthcare Private Company Conference

BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Pear Therapeutics to Participate in the 2020 RBC Capital Mar... See more »
November 23, 2020Business Wire

Pear Therapeutics to Participate in Evercore ISI 3rd Annual HealthCONx Conference

BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Pear Therapeutics to Participate in Evercore ISI 3rd Annual ... See more »
November 19, 2020Business Wire

Pear Therapeutics and Health Transformation Alliance Join in Providing Access for reSET and reSET-O to Self-insured Employers

BOSTON & WESTMONT, N.J.--(BUSINESS WIRE)--Pear Therapeutics and Health Transformation Alliance Join i... See more »
October 8, 2020Business Wire

Pear Therapeutics to Participate in Upcoming Investor Conferences

BOSTON--(BUSINESS WIRE)--Pear Therapeutics to Participate in Upcoming Investor Conferences... See more »
September 10, 2020Business Wire

Pear Therapeutics to Participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference

BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Pear Therapeutics to Participate in the Morgan Stanley Virtu... See more »

Social Media

Pear Headquarters

200 State Street 13th Floor

Boston, Massachusetts02109

617-925-7848

Driving Directions »

Trending Companies

Pear Summary

ABOUT

Overview

Pear Therapeutics is a prescription digital therapeutic platform that offers clinical engagement and patient tracking solutions for clinicians. Pear was founded in 2013. Pear's headquarters is located in Boston, Massachusetts, USA 02109. It has raised...

CEO

Pear's President & CEO, Corey McCann, currently has an approval rating of 91%. Pear's primary competitors are Omada Health, Click Therapeutics & Kaia Health.

Frequently Asked Questions about Pear

  1. When was Pear founded?

    Pear was founded in 2013
  2. Who is Pear's CEO?

    Pear's CEO is Corey McCann
  3. How much revenue does Pear generate?

    Pear generates $13.8M in revenue
  4. How much funding does Pear have?

    Pear has historically raised $284.3M in funding
  1. Where is Pear's headquarters?

    Pear's headquarters is in Boston Massachusetts, USA
  2. How many employees does Pear have?

    Pear has 200 employees
  3. What sector does Pear operate in?

    Pear is in Application Software, Internet Software
  4. Who are Pear's competitors?

    Pear's top competitors are Omada Health, Click Therapeutics, Kaia Health